Peer-reviewedCC BY-NCInfectious diseases & clinical microbiology
Serum Galectin-3 in Diabetic Foot Infections: A Case-Control Evaluation of Its Diagnostic and Severity-Grading Utility
- 1Department of Infectious Diseases and Clinical Microbiology, Yüksekova State Hospital, Hakkari, Türkiye
- 2Department of Infectious Diseases and Clinical Microbiology, Necmettin Erbakan University School of Medicine, Konya, Türkiye
Related
- Diabetic hand infections: a case series highlighting diagnostic and therapeutic challenges.
- Formulation, physicochemical characterization, and antimicrobial evaluation of drug-loaded essential oil microemulsions against Methicillin-resistant Staphylococcus aureus -associated diabetic foot ulcer infections
- Diabetic sarcopenia in clinical practice: expert consensus and usability evaluation of a novel screening and diagnostic algorithm.
- Diagnostic value of tear Galectin-1 and Galectin-3 in keratoconus: a prospective case-control study.
- Clinical characteristics, pathogen detection, and severity markers among children with acute respiratory infections during the COVID-19 restriction period: a retrospective hospital-based study
BibTeX
@article{ataseveryuce2026serum,
title = {{Serum Galectin-3 in Diabetic Foot Infections: A Case-Control Evaluation of Its Diagnostic and Severity-Grading Utility}},
author = {Sümeyye Atasever-Yüce and Bahar Kandemir and Rukiyye Bulut and İbrahim Erayman},
journal = {Infectious diseases \& clinical microbiology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13654395},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Serum Galectin-3 in Diabetic Foot Infections: A Case-Control Evaluation of Its Diagnostic and Severity-Grading Utility
AU - Sümeyye Atasever-Yüce
AU - Bahar Kandemir
AU - Rukiyye Bulut
AU - İbrahim Erayman
PY - 2026
DA - 2026/10/16
JO - Infectious diseases & clinical microbiology
UR - https://europepmc.org/article/PMC/PMC13654395
SN - 2667-646X
ER -